# The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

Study · id `cardio:ct-nct05811364` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05811364](<https://clinicaltrials.gov/study/NCT05811364>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05811364

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.

## Technical summary

Registry record NCT05811364. Randomized; double masking; primary purpose treatment. Start 2023-10-17 (actual); primary completion 2028-03-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 244 participants (planned count; ClinicalTrials.gov record NCT05811364, source copy `cardio:ctgov-nct05811364-2026-05-13`, retrieved 2026-10-31)
- Started: 2023-10-17 (actual) (ClinicalTrials.gov record NCT05811364, source copy `cardio:ctgov-nct05811364-2026-05-13`, retrieved 2026-10-31)
- Primary completion: 2028-03-30 (anticipated) (ClinicalTrials.gov record NCT05811364, source copy `cardio:ctgov-nct05811364-2026-05-13`, retrieved 2026-10-31)
- Completion: 2032-01-31 (anticipated) (ClinicalTrials.gov record NCT05811364, source copy `cardio:ctgov-nct05811364-2026-05-13`, retrieved 2026-10-31)
- Countries: United States; Australia; Germany; Italy; Netherlands; New Zealand; United Kingdom (ClinicalTrials.gov record NCT05811364, source copy `cardio:ctgov-nct05811364-2026-05-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05811364-2026-05-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Condition: Aortoiliac Occlusive Disease
- Condition: Peripheral Arterial Disease
- Intervention (Device): Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
- Intervention (Device): Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: 5156d692f33edeb15fd09887c380051c9f60111eff9ed0cd77ef01f74302913c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
